Whitehawk Therapeutics, Inc.
WHWK
$1.57
$0.031.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.27M | -12.55M | -14.58M | -18.29M | -16.27M |
| Total Depreciation and Amortization | 47.00K | 47.00K | 49.00K | 50.00K | 44.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.75M | 2.34M | 2.57M | 3.34M | 2.74M |
| Change in Net Operating Assets | 1.43M | -5.53M | 2.81M | -4.75M | 3.84M |
| Cash from Operations | -15.05M | -15.69M | -9.16M | -19.65M | -9.64M |
| Capital Expenditure | -186.00K | -188.00K | -541.00K | -739.00K | -816.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.32M | 5.27M | -3.03M | 11.29M | 4.47M |
| Cash from Investing | 13.13M | 5.09M | -3.57M | 10.56M | 3.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 52.00K | 0.00 | 94.00K | -- | 114.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.00K | 0.00 | -7.00K | -10.00K | -34.00K |
| Cash from Financing | 53.00K | 0.00 | 87.00K | -10.00K | 80.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.87M | -10.60M | -12.64M | -9.11M | -5.92M |